Results 141 to 150 of about 1,121 (157)

Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing

Journal of Bone and Mineral Research, 2020
Iris R Hartley, Michael T Collins
openaire   +2 more sources

Burosumab/calcitriol/phosphates

Reactions Weekly
openaire   +2 more sources

Burosumab bei XLH anhaltend wirksam

Pädiatrie, 2022
openaire   +1 more source

Burosumab treatment of children with X-linked hypophosphataemic rickets

The Lancet, 2019
Rebecca J, Gordon, Michael A, Levine
openaire   +2 more sources

Alfacalcidol/burosumab/phosphates

Reactions Weekly
openaire   +1 more source

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Journal of Bone and Mineral Research, 2018
Karl Insogna, Hae Il Cheong, Peter Kamenicky   +2 more
exaly  

Alfacalcidol/burosumab/cinacalcet

Reactions Weekly
openaire   +1 more source

Alfacalcidol/burosumab/unspecified phosphates

Reactions Weekly
openaire   +1 more source

Burosumab-related severe hypercalcaemia

Reactions Weekly
openaire   +1 more source

Examining the Effect of Burosumab on Muscle Function

Case Medical Research, 2019
openaire   +1 more source